Skip to main content

Articles

Page 207 of 331

  1. Mainstreaming genetic medicine, increased media coverage and clinical trials for BRCA mutation carriers are leading oncologists into more patient discussions about BRCA genetic testing. BRCA variants of uncertain...

    Authors: B. K. Eccles, E. Copson, T. Maishman, J. E. Abraham and D. M. Eccles
    Citation: BMC Cancer 2015 15:936
  2. Osteoprotegerin (OPG) is a glycoprotein that has multifaceted role and is associated with several cancer malignancies like that of bladder carcinoma, gastric carcinoma, prostate cancer, multiple myeloma and br...

    Authors: Sudeshna Goswami and Neelam Sharma-Walia
    Citation: BMC Cancer 2015 15:935
  3. Lower lung cancer survival rates in Britain and Denmark compared with surrounding countries may, in part, be due to late diagnosis. The aim of this study was to evaluate the effect of direct access to low-dose...

    Authors: Louise Mahncke Guldbrandt, Morten Fenger-Grøn, Torben Riis Rasmussen, Finn Rasmussen, Peter Meldgaard and Peter Vedsted
    Citation: BMC Cancer 2015 15:934
  4. Tumor susceptibility gene 101 (TSG101) was initially identified in fibroblasts as a tumor suppressor gene but subsequent studies show that TSG101 also functions as a tumor-enhancing gene in some epithelial tum...

    Authors: Xu Bin Sai, Tomohiko Makiyama, Hiroshi Sakane, Yukimi Horii, Hideyuki Hiraishi and Hiromichi Shirataki
    Citation: BMC Cancer 2015 15:933
  5. In the era of intensity-modulated radiotherapy (IMRT), the efficacy of additional neoadjuvant chemotherapy (NACT) to concurrent chemoradiotherapy (CCRT) in locoregionally advanced nasopharyngeal carcinoma (NPC...

    Authors: Yu-Pei Chen, Wen-Na Zhang, Ling-Long Tang, Yan-Ping Mao, Xu Liu, Lei Chen, Guan-Qun Zhou, Hai-Qiang Mai, Jian-Yong Shao, Wei-Hua Jia, Tie-Bang Kang, Mu-Sheng Zeng, Ying Sun and Jun Ma
    Citation: BMC Cancer 2015 15:930
  6. Over-treatment of estrogen receptor positive (ER+), lymph node-negative (LNN) breast cancer patients with chemotherapy is a pressing clinical problem that can be addressed by improving techniques to predict tu...

    Authors: K. Burke, M. Smid, R. P. Dawes, M. A. Timmermans, P. Salzman, C. H. M. van Deurzen, David G. Beer, J. A. Foekens and E. Brown
    Citation: BMC Cancer 2015 15:929
  7. Doxorubicin (Dox) is widely used to treat progressed bladder cancer after transurethral resection. The use of Dox-chemotherapy has been limited due to induced drug resistance and cumulative cardiotoxic effects...

    Authors: Dmitriy Smolensky, Kusum Rathore and Maria Cekanova
    Citation: BMC Cancer 2015 15:927
  8. Median overall survival (OS) of patients with melanoma brain metastases (MBM) is usually 6 months or less. There are rare reports of patients with treated MBM who survived for years. These outlier cases repres...

    Authors: Sarah Weiss, Farbod Darvishian, Jyothi Tadepalli, Richard Shapiro, John Golfinos, Anna Pavlick, David Polsky, Tomas Kirchhoff and Iman Osman
    Citation: BMC Cancer 2015 15:926
  9. Better methods to predict prognosis can play a supplementary role in administering individualized treatment for breast cancer patients. Altered expressions of PTHrP and TGF-β have been observed in various type...

    Authors: Cheng Xu, Zhengyuan Wang, Rongrong Cui, Hongyu He, Xiaoyan Lin, Yuan Sheng and Hongwei Zhang
    Citation: BMC Cancer 2015 15:925
  10. Although the association between H. pylori and gastric cancer has been well described, the alterations studies are scarce in the humoral immune response in specific anatomical areas of stomach and during the stag...

    Authors: López-Vidal Yolanda, Ponce-de-León Sergio, Esquivel-Solís Hugo, Amieva-Fernández Rosa Isabel, Barreto-Zúñiga Rafael, Torre-Delgadillo Aldo and Castillo-Rojas Gonzalo
    Citation: BMC Cancer 2015 15:924
  11. Current evidence supports a diverting stoma in patients undergoing low anterior resection with total mesorectal excision for rectal cancer as it reduces clinical severity of anastomotic leakage. However, relev...

    Authors: Flavius Sandra-Petrescu, Florian Herrle, Axel Hinke, Inga Rossion, Heiko Suelberg, Stefan Post, Ralf-Dieter Hofheinz and Peter Kienle
    Citation: BMC Cancer 2015 15:923
  12. Cell fusion is a natural process in normal development and tissue regeneration. Fusion between cancer cells and macrophages generates metastatic hybrids with genetic and phenotypic characteristics from both ma...

    Authors: Ivan Shabo, Kristine Midtbö, Henrik Andersson, Emma Åkerlund, Hans Olsson, Pia Wegman, Cecilia Gunnarsson and Annelie Lindström
    Citation: BMC Cancer 2015 15:922
  13. Socioeconomic position (SEP) has been associated with breast cancer incidence and survival. We examined the associations between two socioeconomic indicators and long-term breast cancer incidence and survival ...

    Authors: Mandy Goldberg, Ronit Calderon-Margalit, Ora Paltiel, Wiessam Abu Ahmad, Yechiel Friedlander, Susan Harlap and Orly Manor
    Citation: BMC Cancer 2015 15:921
  14. Glutathione S-transferase P1 (GSTP1) has been reported to function as a tumor suppressor gene in various types of human cancers. Aberrant methylation of tumor-related genes at the promoter regions can inactivate ...

    Authors: Cheng Fang, Xue-Mei Wei, Xian-Tao Zeng, Fu-Bing Wang, Hong Weng and Xinghua Long
    Citation: BMC Cancer 2015 15:920
  15. Colorectal cancer is the third most common malignancy in humans and novel therapeutic approaches are urgently needed. Autophagy is an evolutionarily highly conserved cellular process by which cells collect unn...

    Authors: Bruno Christian Koehler, Adam Jassowicz, Anna-Lena Scherr, Stephan Lorenz, Praveen Radhakrishnan, Nicole Kautz, Christin Elssner, Johanna Weiss, Dirk Jaeger, Martin Schneider and Henning Schulze-Bergkamen
    Citation: BMC Cancer 2015 15:919
  16. Papillary thyroid cancer is the most common endocrine malignancy. The most sensitive and specific diagnostic tool for thyroid nodule diagnosis is fine-needle aspiration (FNA) biopsy with cytological evaluation...

    Authors: Federica Panebianco, Chiara Mazzanti, Sara Tomei, Paolo Aretini, Sara Franceschi, Francesca Lessi, Giancarlo Di Coscio, Generoso Bevilacqua and Ivo Marchetti
    Citation: BMC Cancer 2015 15:918
  17. Standardized chemotherapy used in cancer patients with severe kidney insufficiency is ineffective. Although there are some pharmacokinetic studies on cyclophosphamide in kidney insufficiency patients, to the b...

    Authors: Liu Yang, Xiao-chen Zhang, Su-feng Yu, Hua-Qing Zhu, Ai-ping Hu, Jian Chen and Peng Shen
    Citation: BMC Cancer 2015 15:917
  18. There is limited information about the clinical and biological significance of prostate specific G protein coupled receptor (PSGR) in prostate cancer (PCa) initiation and progression. Here, we evaluated the ex...

    Authors: Wenqing Cao, Faqian Li, Jorge Yao and Jiangzhou Yu
    Citation: BMC Cancer 2015 15:915
  19. Paraneoplastic neurological syndrome (PNS) is a heterogeneous group of disorders affecting any part of the nervous system, in a patient affected by cancer. PNS is estimated to occur in 0.01 to 8 % of cancer pa...

    Authors: Maria Pia Brizzi, Cristina Sonetto, Marco Tampellini, Massimo Di Maio, Marco Volante and Giorgio V. Scagliotti
    Citation: BMC Cancer 2015 15:914
  20. Abnormal glucose and lipids levels may impact survival after breast cancer (BC) diagnosis, but their association to other causes of mortality such as cardiovascular (CV) disease may result in a competing risk ...

    Authors: Wahyu Wulaningsih, Mariam Vahdaninia, Mark Rowley, Lars Holmberg, Hans Garmo, Håkan Malmstrom, Mats Lambe, Niklas Hammar, Göran Walldius, Ingmar Jungner, Anthonius C. Coolen and Mieke Van Hemelrijck
    Citation: BMC Cancer 2015 15:913
  21. Current knowledge of the aetiology of hereditary breast cancer in the four main South African population groups (black, coloured, Indian and white) is limited. Risk assessments in the black, coloured and India...

    Authors: F. Z. Francies, T. Wainstein, K. De Leeneer, A. Cairns, M. Murdoch, S. Nietz, H. Cubasch, B. Poppe, T. Van Maerken, B. Crombez, I. Coene, R. Kerr, J. P. Slabbert, A. Vral, A. Krause, A. Baeyens…
    Citation: BMC Cancer 2015 15:912
  22. Exportin 1 (XPO1) is a well-characterized nuclear export protein whose expression is up-regulated in many types of cancers and functions to transport key tumor suppressor proteins (TSPs) from the nucleus. Kary...

    Authors: Marsha Crochiere, Trinayan Kashyap, Ori Kalid, Sharon Shechter, Boris Klebanov, William Senapedis, Jean-Richard Saint-Martin and Yosef Landesman
    Citation: BMC Cancer 2015 15:910
  23. Hepatocellular carcinoma (HCC) is the most common form of liver cancer and the third most lethal cancer worldwide. The epithelial to mesenchymal transition (EMT) describes the transformation of well-differenti...

    Authors: Philipp Wittmann, Markus Grubinger, Christian Gröger, Heidemarie Huber, Wolfgang Sieghart, Markus Peck-Radosavljevic and Wolfgang Mikulits
    Citation: BMC Cancer 2015 15:909
  24. The aim of this study was to detect the epidermal growth factor receptor (EGFR)-activating mutations and other oncogene alterations in patients with non-small-cell lung cancers (NSCLC) who experienced a treatm...

    Authors: Katsuhiro Masago, Shiro Fujita, Miho Muraki, Akito Hata, Chiyuki Okuda, Kyoko Otsuka, Reiko Kaji, Jumpei Takeshita, Ryoji Kato, Nobuyuki Katakami and Yukio Hirata
    Citation: BMC Cancer 2015 15:908
  25. Disadvantaged populations face many barriers to cancer care, including limited support in navigating through the complexities of the healthcare system. Family members play an integral role in caring for patien...

    Authors: Olive Mbah, Jean G. Ford, Miaozhen Qiu, Jennifer Wenzel, Lee Bone, Janice Bowie, Ahmed Elmi, Jimmie L. Slade, Michele Towson and Adrian S. Dobs
    Citation: BMC Cancer 2015 15:907
  26. Nasopharyngeal carcinoma (NPC), also known as Cantonese cancer, is rare worldwide, but has particularly high incidence in North Africa and Southeast Asia, especially in Guangdong, China, such as Guangzhou. Tob...

    Authors: Jia-Huang Lin, Chao-Qiang Jiang, Sai-Yin Ho, Wei-Sen Zhang, Zhi-Ming Mai, Lin Xu, Ching-Man Lo and Tai-Hing Lam
    Citation: BMC Cancer 2015 15:906
  27. BRF2 is a transcription factor required for synthesis of a small group of non-coding RNAs by RNA polymerase III. Overexpression of BRF2 can transform human mammary epithelial cells. In both breast and lung can...

    Authors: Jana Koo, Stephanie Cabarcas-Petroski, John L. Petrie, Nicole Diette, Robert J. White and Laura Schramm
    Citation: BMC Cancer 2015 15:905
  28. The aim of the trial is to demonstrate that with the use of modern IMRT/IGRT and reduction of safety margins postoperative wound complications can be reduced.

    Authors: Barbara Röper, Christine Heinrich, Victoria Kehl, Hans Rechl, Katja Specht, Klaus Wörtler, Andreas Töpfer, Michael Molls, Severin Kampfer, Rüdiger von Eisenharth-Rothe and Stephanie E. Combs
    Citation: BMC Cancer 2015 15:904
  29. Although postoperative adjuvant chemoradiotherapies prevent recurrence for some patients with ampullary cancer, the recurrence rate is as high as 29 % in patients with stage I cancer. In an effort to identify ...

    Authors: Cheng-Lin Wu, Ying-Jui Chao, Ta-Ming Yang, Yi-Ling Chen, Kung-Chao Chang, Hui-Ping Hsu, Yan-Shen Shan and Ming-Derg Lai
    Citation: BMC Cancer 2015 15:903
  30. The purpose of this study was to review patient characteristics and evaluate the potential factors affecting prognosis in cases of brain metastasis (BM) from colorectal cancer (CRC).

    Authors: Xiao-Dong Gu, Yan-Tao Cai, Yi-Ming Zhou, Zhen-Yang Li, Jian-Bin Xiang and Zong-You Chen
    Citation: BMC Cancer 2015 15:902
  31. AXL is a well-characterized, protumorigenic receptor tyrosine kinase that is highly expressed and activated in numerous human carcinomas and sarcomas, including aggressive subtypes of liposarcoma. However, the...

    Authors: Caitlin D. May, Jeannine Garnett, XiaoYan Ma, Sharon M. Landers, Davis R. Ingram, Elizabeth G. Demicco, Ghadah A. Al Sannaa, Tona Vu, Lixia Han, Yi Zhang, Christine M. Kivlin, Svetlana Bolshakov, Azad Abul Kalam, Juehui Liu, Fuguo Zhou, Dominique Broccoli…
    Citation: BMC Cancer 2015 15:901
  32. Antiangiogenic treatments have been shown to increase blood perfusion and oxygenation in some experimental tumors, and to reduce blood perfusion and induce hypoxia in others. The purpose of this preclinical st...

    Authors: Jon-Vidar Gaustad, Trude G. Simonsen, Ragnhild Smistad, Catherine S. Wegner, Lise Mari K. Andersen and Einar K. Rofstad
    Citation: BMC Cancer 2015 15:900
  33. Return-to-work (RTW)-interventions support cancer survivors in resuming work, but come at additional healthcare costs. The objective of this study was to assess the budget impact of a RTW-intervention, consist...

    Authors: Janne C. Mewes, Lotte M. G. Steuten, Iris F. Groeneveld, Angela G. E. M. de Boer, Monique H. W. Frings-Dresen, Maarten J. IJzerman and Wim H. van Harten
    Citation: BMC Cancer 2015 15:899
  34. Irisin is a recently discovered myokine, involved in the browning of white adipose tissue. To date, its function has been mainly associated with energy homeostasis and metabolism, and it has been proposed as a...

    Authors: Xeni Provatopoulou, Georgia P. Georgiou, Eleni Kalogera, Vasileios Kalles, Maira A. Matiatou, Ioannis Papapanagiotou, Alexandros Sagkriotis, George C. Zografos and Antonia Gounaris
    Citation: BMC Cancer 2015 15:898
  35. Disseminated tumor cells (DTCs) can be detected using ultrasensitive immunocytochemical assays and their presence in the bone marrow can predict the subsequent occurrence of overt metastasis formation and meta...

    Authors: Stefan Werner, Hauke Stamm, Mutiha Pandjaitan, Dirk Kemming, Benedikt Brors, Klaus Pantel and Harriet Wikman
    Citation: BMC Cancer 2015 15:896
  36. Chondrosarcoma is characterized for its lack of response to conventional cytotoxic chemotherapy, propensity for developing lung metastases, and low rates of survival. Research within the field of development a...

    Authors: Birgit Lohberger, Andreas Leithner, Nicole Stuendl, Heike Kaltenegger, Werner Kullich and Bibiane Steinecker-Frohnwieser
    Citation: BMC Cancer 2015 15:891
  37. Approximately 10–15 % of gastrointestinal stromal tumors (GISTs) lack gain of function mutations in the KIT and platelet-derived growth factor receptor alpha (PDGFRA) genes. An alternate mechanism of oncogenesis ...

    Authors: Martin G. Belinsky, Lori Rink, Kathy Q. Cai, Stephen J. Capuzzi, Yen Hoang, Jeremy Chien, Andrew K. Godwin and Margaret von Mehren
    Citation: BMC Cancer 2015 15:887
  38. USP18 (ubiquitin-specific protease 18) removes ubiquitin-like modifier interferon stimulated gene 15 (ISG15) from conjugated proteins. USP18 null mice in a FVB/N background develop tumors as early as 2 months ...

    Authors: Fadzai Chinyengetere, David J. Sekula, Yun Lu, Andrew J. Giustini, Aarti Sanglikar, Masanori Kawakami, Tian Ma, Sandra S. Burkett, Burton L. Eisenberg, Wendy A. Wells, Paul J. Hoopes, Elizabeth G. Demicco, Alexander J Lazar, Keila E. Torres, Vincent Memoli, Sarah J. Freemantle…
    Citation: BMC Cancer 2015 15:886
  39. Cyclin-dependent protein kinase-5 (CDK5) is an unusual member of the CDK family as it is not cell cycle regulated. However many of its substrates have roles in cell growth and oncogenesis, raising the possibil...

    Authors: Nicola J. Grant, Philip J. Coates, Yvonne L. Woods, Susan E. Bray, Nicholas A. Morrice, C. James Hastie, Douglas J. Lamont, Francis A. Carey and Calum Sutherland
    Citation: BMC Cancer 2015 15:885
  40. Mucinous adenocarcinoma (MAC) represents 6-19 % of all colorectal carcinoma. It is associated with poorer response to chemotherapy and chemoradiotherapy.

    Authors: Karolina Vernmark, Maria Albertsson, Bergthor Björnsson, Thomas Gasslander, Per Sandström, Xiao-Feng Sun and Annika Holmqvist
    Citation: BMC Cancer 2015 15:884
  41. The development of androgen resistance is a major limitation to androgen deprivation treatment in prostate cancer. We have developed an in vitro model of androgen-resistance to characterise molecular changes occu...

    Authors: Sujitra Detchokul, Aparna Elangovan, Edmund J. Crampin, Melissa J. Davis and Albert G. Frauman
    Citation: BMC Cancer 2015 15:883
  42. Recurrence of colorectal cancer (CRC) may arise due to the persistence of drug-resistant and cancer-initiating cells that survive exposure to chemotherapy. Proteins responsible for this recurrence include the ...

    Authors: Murray J. Cutler, Erica L. Lowthers, Cynthia L. Richard, Dagmar M. Hajducek, Paul A. Spagnuolo and Jonathan Blay
    Citation: BMC Cancer 2015 15:882

Featured videos

View featured videos from across the BMC-series journals